Mst Continus (Morphine)

Morphine, the active ingredient in Mst Continus, is an opioid analgesic presented as a tablet (strength unspecified) for oral use. It provides analgesia for moderate to severe pain in adult patients.

GNH USA supplies Mst Continus as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mst Continus (morphine) is employed in the management of pain conditions that require strong opioid therapy.

Acute postoperative pain: provides effective relief after surgical procedures. Cancer‑related pain: controls severe pain associated with malignant disease. Chronic non‑cancer pain: offers long‑term analgesia when other treatments are insufficient.

Morphine may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects: - Nausea and vomiting - Constipation - Drowsiness or sedation - Dizziness - Dry mouth - Sweating

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Allergic reactions (rash, pruritus, anaphylaxis) - Adrenal insufficiency - Seizures - Opioid‑induced neurotoxicity

When prescribing or dispensing morphine, consider the following safety measures.

Assess pain severity and treatment goals: tailor therapy to individual needs. Monitor respiratory function: watch for signs of depression, especially after dose changes. Adjust dose in renal or hepatic impairment: reduced clearance may increase toxicity. Avoid concurrent CNS depressants: limit additive sedation or respiratory effects. Use caution in elderly patients: increased sensitivity to opioid effects. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Morphine interacts with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Other opioids or strong CNS depressants (e.g., benzodiazepines, barbiturates): risk of profound respiratory depression. - Monoamine oxidase inhibitors (MAOIs): can precipitate severe hypertension or serotonin syndrome. - Respiratory stimulants withdrawn abruptly: may cause rebound respiratory depression.

Moderate Interactions (Monitor Closely):\n- Anticholinergic agents: may worsen constipation. - Diuretics: can enhance orthostatic hypotension. - Antihistamines: may increase sedation. - Selective serotonin reuptake inhibitors (SSRIs): monitor for serotonin syndrome signs. - CYP3A4 inhibitors (e.g., ketoconazole): may increase morphine plasma levels.